Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 29, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Breast Neoplasm FemaleMetastatic Breast Cancer
Interventions
DRUG

Disulfiram

"Patients will take one pill of disulfiram (Antabus) daily at a dose of 400 mg continually during the treatment phase (from day 0 till End of treatment Visit). In case of intolerance, lower dose up to 200 mg per day is allowed.~Copper supplementation will be given separately from disulfiram; in the morning with patients´breakfast. Patients will take one pill of copper dietary supplement (for instance Copper Star, STARLIFE) corresponding to 2 mg of elementary copper."

Trial Locations (1)

77900

RECRUITING

University Hospital Olomouc, Olomouc

All Listed Sponsors
collaborator

University Hospital Olomouc

OTHER

lead

The Institute of Molecular and Translational Medicine, Czech Republic

OTHER